RenovoRx Insider Shaun Bagai Files Form 4 Ownership Statement

TL;DR

**RenovoRx insider Shaun Bagai filed a Form 4, signaling a change in his stock ownership.**

AI Summary

This Form 4 filing, dated March 24, 2026, reports that Shaun Bagai, an insider at RenovoRx, Inc., has filed a statement of changes in beneficial ownership of securities. While the filing itself doesn't detail specific transactions, it indicates that Mr. Bagai, CIK 0001862613, is a reporting person for RenovoRx, Inc. (CIK 0001574094). This matters to investors because insider filings can signal management's confidence (or lack thereof) in the company's future, potentially influencing stock price movements.

Why It Matters

This filing signals that an insider at RenovoRx, Inc. has had a change in their ownership of company securities, which can be an important indicator for investors.

Risk Assessment

Risk Level: low — This filing is purely informational and does not inherently present a direct financial risk, but rather provides data for investor analysis.

Analyst Insight

A smart investor would use this filing as a prompt to investigate the specific transactions detailed within the full Form 4 document to understand the nature of Shaun Bagai's change in ownership (e.g., a purchase, sale, or grant) and assess its potential implications for RenovoRx, Inc.'s stock.

Key Players & Entities

• Shaun Bagai (person) — Reporting Person
• RenovoRx, Inc. (company) — Issuer of securities
• 0001862613 (person) — CIK for Shaun Bagai
• 0001574094 (company) — CIK for RenovoRx, Inc.
• 2026-03-24 (date) — Filing Date

FAQ

Key Financial Figures

• $25,000 — t on March 20, 2026 for an aggregate of $25,000. 2. The warrants are exercisable immed
• $1.5 million — ng the date the Issuer reports at least $1.5 million in product sales revenue (excluding lic

Filing Documents

• ownership.html (4)
• ownership.xml (4) — 7KB
• 0001493152-26-012482.txt ( ) — 8KB

From the Filing

SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * Bagai Shaun (Last) (First) (Middle) C/O RENOVORX, INC. 2570 W EL CAMINO REAL, SUITE 320 (Street) MOUNTAIN VIEW CALIFORNIA 94040 (City) (State) (Zip) UNITED STATES (Country) 2. Issuer Name and Ticker or Trading Symbol RenovoRx, Inc. [ RNXT ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner X Officer (give title below) Other (specify below) Chief Executive Officer 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 03/20/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 03/20/2026 03/20/2026 P 24,300 A (1) 313,357 (3) I The Bagai Family Trust Common Stock 50,983 (3) D Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Warrants $ 1.9326 03/20/2026 03/20/2026 P 12,150 (2) (2) Common Stock 12,150 (1) 12,150 I The Bagai Family Trust Explanation of Responses: 1. The securities were purchased in a private placement on March 20, 2026 for an aggregate of $25,000. 2. The warrants are exercisable immediately upon issuance and expire on the earlier of (i) March 30, 2029 or (ii) 30 days following the date the Issuer reports at least $1.5 million in product sales revenue (excluding licensing fees, upfront milestones and grants, but including royalty revenue from product sales) for any calendar quarter in a quarterly or annual report. 3. 289,057 shares of common stock are held of record by The Bagai Family Trust and were previously reported as "directly" beneficially held by the Reporting Person. /s/ Shaun Bagai 03/24/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. * Form 4: SEC 1474 (03-26)

View Full Filing

View this 4 filing on SEC EDGAR